TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials

TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials

[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-11, Vol.68 (18), p.B41-B42
Hauptverfasser: Shah, Rahman, Hwang, Inyong Hwang, Nayyar, Mannu, Slomka, Teresa, Rashid, Abdul
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Cardiology
Cardiovascular
Internal Medicine
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]both decreased the stent thrombosis rate compared with clopidogrel, prasugrel being the more effective of the two.Ticagrelor use was also associated with improved all-cause mortality compared with clopidogrel; no difference was found between prasugrel and clopidogrel.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.09.348